Charite University, Berlin, Germany: Urticaria trials
The registry lists 15 Urticaria studies with Charite University, Berlin, Germany as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 2 8Phase 3 4Phase 4 2No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Urticaria Facticia Treatment With Omalizumab (UFO)CompletedNCT02169115Phase 2Results posted
- Safety Study of Levocetirizine and FexofenadineCompletedNCT01586091Phase 4Results posted
- Cold Urticaria Treatment With XolairCompletedNCT01580592Phase 2Results posted
- Cholinergic Urticaria - Efficacy of DupilumabCompletedNCT03749148Phase 2
- Dupilumab in Chronic Spontaneous UrticariaCompletedNCT03749135Phase 2
- Chronic Urticaria - Long Term Assessment of Effects of RupatadineTerminatedNCT02358265Phase 3
- Bilastine Updosing in Chronic Spontaneous UrticariaCompletedNCT02213367Phase 3
- Cold Contact Urticaria Treatment With RilonaceptCompletedNCT02171416Phase 2
- Validation of an Urticaria Control TestCompletedNCT01614834
- Development of an Urticaria Control TestCompletedNCT01610128
- Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold UrticariaCompletedNCT01605487Phase 2
- Bilastine Updosing - Characterization of Underlying MechanismsCompletedNCT01271075Phase 2/3
- Ilaris® in Urticarial Vasculitis - Investigation of Treatment ResponsesCompletedNCT01170936Phase 2
- A Study to Assess and Compare the Effects of 5 mg vs. 20 mg Desloratadine on the Development of Cold Urticaria LesionsCompletedNCT00600847Phase 4
- Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)CompletedNCT00598611Phase 3